KINLYTIC Trademark

Trademark Overview


On Thursday, April 4, 2019, a trademark application was filed for KINLYTIC with the United States Patent and Trademark Office. The USPTO has given the KINLYTIC trademark a serial number of 88371738. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 24, 2022. This trademark is owned by MICROBIX BIOSYSTEMS INC.. The KINLYTIC trademark is filed in the Pharmaceutical Products category with the following description:

Antithrombotic drugs; Medical preparations for treating pulmonary conditions; thrombolytic drugs; Urokinase preparations for treating blood clots; Urokinase preparations for treating blood clots, administered intravenously; Urokinase preparations for clearing catheters and cannulas; Urokinase preparations for the restoration of patency to intravenous catheter, including central venous catheter, obstructed by clotted blood or fibrin; Urokinase preparations for treating pulmonary embolism; Urokinase preparations for treating the lysis of acute pulmonary emboli and pulmonary emboli accompanied by unstable hemodynamics; Urokinase preparations for treating thrombosis; Urokinase preparations for treating coronary artery thrombosis; Urokinase preparations for treating myocardial infarction; Urokinase preparations for the lysis of thrombi; Urokinase preparations for treating peripheral arterial and graft thromboembolic occlusion; Urokinase preparations for treating deep vein thrombosis; Urokin...
kinlytic

General Information


Serial Number88371738
Word MarkKINLYTIC
Filing DateThursday, April 4, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 24, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements


Goods and ServicesAntithrombotic drugs; Medical preparations for treating pulmonary conditions; thrombolytic drugs; Urokinase preparations for treating blood clots; Urokinase preparations for treating blood clots, administered intravenously; Urokinase preparations for clearing catheters and cannulas; Urokinase preparations for the restoration of patency to intravenous catheter, including central venous catheter, obstructed by clotted blood or fibrin; Urokinase preparations for treating pulmonary embolism; Urokinase preparations for treating the lysis of acute pulmonary emboli and pulmonary emboli accompanied by unstable hemodynamics; Urokinase preparations for treating thrombosis; Urokinase preparations for treating coronary artery thrombosis; Urokinase preparations for treating myocardial infarction; Urokinase preparations for the lysis of thrombi; Urokinase preparations for treating peripheral arterial and graft thromboembolic occlusion; Urokinase preparations for treating deep vein thrombosis; Urokinase preparations for treating pleural effusions; Urokinase preparations for treating peripheral arterial occlusion; Urokinase preparations for treating ischemic stroke; Urokinase preparations for treating lower limb ischemia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 22, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMICROBIX BIOSYSTEMS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L4Z1P3
CA

Party NameMICROBIX BIOSYSTEMS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L4Z1P3
CA

Trademark Events


Event DateEvent Description
Monday, October 24, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 24, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 22, 2022SOU EXTENSION 5 GRANTED
Thursday, January 20, 2022SOU EXTENSION 5 FILED
Thursday, January 20, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 22, 2021SOU EXTENSION 4 GRANTED
Friday, September 17, 2021SOU EXTENSION 4 FILED
Wednesday, September 22, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 17, 2021SOU TEAS EXTENSION RECEIVED
Saturday, February 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 4, 2021SOU EXTENSION 3 GRANTED
Thursday, February 4, 2021SOU EXTENSION 3 FILED
Thursday, February 4, 2021SOU TEAS EXTENSION RECEIVED
Thursday, August 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 25, 2020SOU EXTENSION 2 GRANTED
Tuesday, August 25, 2020SOU EXTENSION 2 FILED
Tuesday, August 25, 2020SOU TEAS EXTENSION RECEIVED
Thursday, February 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 25, 2020SOU EXTENSION 1 GRANTED
Tuesday, February 25, 2020SOU EXTENSION 1 FILED
Tuesday, February 25, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, September 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 14, 2019ASSIGNED TO EXAMINER
Monday, April 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 8, 2019NEW APPLICATION ENTERED